Serological Testing Versus Other Strategies for Diagnosis of Active Tuberculosis in India: A Cost-Effectiveness Analysis

This cost-effectiveness study shows that sputum smear microscopy is the most cost-effective test for active tuberculosis (TB) in India, and liquid culture plus microscopy is more cost-effective for TB diagnosis than serological tests.

[1]  K. Steingart,et al.  Widespread use of serological tests for tuberculosis: data from 22 high-burden countries , 2012, European Respiratory Journal.

[2]  N. Dendukuri,et al.  Commercial Serological Tests for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis: An Updated Systematic Review and Meta-Analysis , 2011, PLoS medicine.

[3]  Madhukar Pai,et al.  Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis , 2011, PLoS medicine.

[4]  K. Floyd,et al.  A cost-benefit analysis of scaling up tuberculosis control in India. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[5]  Kelly Morris,et al.  WHO recommends against inaccurate tuberculosis tests , 2011, The Lancet.

[6]  Madhukar Pai,et al.  Tuberculosis diagnosis--time for a game change. , 2010, The New England journal of medicine.

[7]  Eduardo Gotuzzo,et al.  Rapid molecular detection of tuberculosis and rifampin resistance. , 2010, The New England journal of medicine.

[8]  Madhukar Pai,et al.  Novel and improved technologies for tuberculosis diagnosis: progress and challenges. , 2009, Clinics in chest medicine.

[9]  K. Unnikrishnan,et al.  Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patients. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  R. Chaisson,et al.  Impact and Cost-Effectiveness of Culture for Diagnosis of Tuberculosis in HIV-Infected Brazilian Adults , 2008, PloS one.

[11]  J. Cunningham.  Diagnostics Evaluation Series No. 2. Laboratory-based evaluation of 19 commercially available rapid diagnostic tests for tuberculosis , 2008 .

[12]  H. Ayles,et al.  Costs and cost-effectiveness of tuberculosis cultures using solid and liquid media in a developing country. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  D. Dowdy,et al.  Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  A. Ramsay,et al.  Evidence-Based Tuberculosis Diagnosis , 2008, PLoS medicine.

[15]  R. Lumb,et al.  Critical appraisal of current recommendations and practices for tuberculosis sputum smear microscopy. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[16]  M. Perkins,et al.  Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. , 2007, The Journal of infectious diseases.

[17]  Paul Nunn,et al.  Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes , 2007, The Lancet.

[18]  K. Steingart,et al.  Commercial Serological Antibody Detection Tests for the Diagnosis of Pulmonary Tuberculosis: A Systematic Review , 2007, PLoS medicine.

[19]  Federico Girosi,et al.  Reducing the global burden of tuberculosis: the contribution of improved diagnostics , 2006, Nature.

[20]  M. Perkins,et al.  Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. , 2006, The Lancet. Infectious diseases.

[21]  R. Chaisson,et al.  The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model , 2006, AIDS.

[22]  M. Perkins,et al.  Progress towards improved tuberculosis diagnostics for developing countries , 2006, The Lancet.

[23]  M. Perkins,et al.  Diagnostics for tuberculosis: global demand and market potential. , 2006 .

[24]  S. Theobald,et al.  'Lost' smear-positive pulmonary tuberculosis cases: where are they and why did we lose them? , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[25]  C Scarparo,et al.  Meta-Analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without Solid Media, for Detection of Mycobacteria , 2004, Journal of Clinical Microbiology.

[26]  N. Michael,et al.  Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.

[27]  Christopher Dye,et al.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.

[28]  A. Ivinson.  Macroeconomics and Health: Investing in Health for Economic Development , 2002, Nature Medicine.

[29]  R. Feachem.  Commission on Macroeconomics and Health. , 2002, Bulletin of the World Health Organization.

[30]  J. Sachs.  Macroeconomics and health: investing in health for economic development , 2002 .

[31]  Hargreaves,et al.  Assessing health seeking behaviour among tuberculosis patients in rural South Africa. , 2001, The International Journal of Tuberculosis and Lung Disease.

[32]  S. Lockman,et al.  Completeness and timeliness of treatment initiation after laboratory diagnosis of tuberculosis in Gaborone, Botswana. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[33]  H. Banda,et al.  Care seeking behaviour and diagnostic processes in patients with smear-positive pulmonary tuberculosis in Malawi. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[34]  M. Behr,et al.  Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli , 1999, The Lancet.

[35]  Peter Piot,et al.  Joint United Nations Program on HIV/AIDS (UNAIDS) , 1997 .

[36]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[37]  Dean T. Jamison,et al.  World development report 1993 : investing in health , 1993 .

[38]  BOMBAY CALCUrIA,et al.  World development report 1993--investing in health. , 1993, Communicable disease report. CDR weekly.

[39]  C. Schofield,et al.  UNDP/World Bank/WHO special programme for research and training in tropical diseases (TDR) , 1989 .

[40]  G W Comstock,et al.  Epidemiology of tuberculosis. , 1982, The American review of respiratory disease.